CTD: Common Technical Document

The Common Technical Document (CTD) is the ICH-agreed five-module structure in which a medicine's quality, safety and efficacy dossier is organised.

Also known as: ICH M4, CTD format, CTD dossier, EU-CTD

3 min readUpdated

Reviewed by Gosia Luksza, CEO at Regunaut

At a glance

Defined by
ICH M4, with M4Q, M4S and M4E for the quality, safety and efficacy parts
Modules
1 regional, 2 summaries, 3 quality, 4 non-clinical reports, 5 clinical reports
EU basis
Annex I to Directive 2001/83/EC; Notice to Applicants, Volume 2B
Mandatory in the EU
Since 1 July 2003

How it works

The Common Technical Document is the agreed way of organising the information in an application for a marketing authorisation. It was developed by the International Council for Harmonisation in guideline M4, with M4Q, M4S and M4E giving the detailed headings for the quality, safety and efficacy parts, so that one dossier can be submitted in the EU, the United States, Japan and the other countries that have adopted the format. The CTD prescribes where information goes, not which studies are needed: content requirements still come from each region's law and guidance. In the EU, Annex I to Directive 2001/83/EC requires applications to be presented in the CTD format, Volume 2B of the Notice to Applicants sets out the EU presentation, and the format has been mandatory since 1 July 2003.

The dossier has five modules. Module 1 is regional and, strictly, not part of the CTD. In the EU it holds the cover letter, the application form, the product information and mock-ups, information about the experts, the environmental risk assessment, the summary of the pharmacovigilance system and the risk management plan, and information on clinical trials and paediatrics. Module 2 contains the summaries: the quality overall summary, the non-clinical and clinical overviews, and the non-clinical and clinical written and tabulated summaries. Module 3 is quality, covering the active substance and the finished product. Module 4 holds the non-clinical study reports and Module 5 the clinical study reports. The structure is usually drawn as a triangle, with Modules 2 to 5 as the common part and Module 1 beside it.

Which modules must be complete depends on the legal basis of the application. A full application contains the applicant's own data in every module. A generic application relies on the reference product for the non-clinical and clinical data and supplies bioequivalence studies in Module 5; a well-established use application fills Modules 4 and 5 with published literature. The numbering is the same for all of them, and sections that do not apply are left out, with the absence justified in the Module 2 overviews. The structure also carries through the life of the product: a variation updates the affected sections, and the overviews are amended where the change needs expert justification. The eCTD is the electronic implementation of this structure, with an XML backbone and lifecycle management added.

What goes wrong

Information placed in the wrong section, so the assessor cannot find it and asks a question that the dossier already answers; overviews in Module 2 that summarise without critical assessment, or that were not updated when Module 3 or 5 changed; documents split at a different granularity from the one ICH recommends, which causes trouble later in the eCTD lifecycle; Module 1 documents prepared for one region and reused in another without adapting them; and a dossier bought from a licensor in an old format, with nobody able to map it to the current headings. A dossier that is easy to navigate draws fewer avoidable questions, and every question answered during a clock-stop adds calendar time.

What teams do with it in Regunaut

Jobs in the platform that turn on CTD, each part of a wider workflow.

CTD: common questions

What is the difference between CTD and eCTD?

The CTD is the structure: five modules and their headings, agreed in ICH M4. The eCTD is the electronic format that carries a dossier in that structure, with an XML backbone, document metadata and lifecycle operations for later submissions. Every eCTD follows the CTD, but a CTD dossier is not necessarily an eCTD.

What are the five modules of the CTD?

Module 1 holds regional administrative information and the product information. Module 2 holds the quality overall summary and the non-clinical and clinical overviews and summaries. Module 3 is quality: the chemical, pharmaceutical and biological documentation. Module 4 contains the non-clinical study reports and Module 5 the clinical study reports.

Is Module 1 part of the CTD?

Strictly, no. The CTD harmonises Modules 2 to 5, which are common to all ICH regions. Module 1 is defined by each region. In the EU its content is set out in Volume 2B of the Notice to Applicants and includes the application form, the SmPC, labelling and package leaflet, the environmental risk assessment and the pharmacovigilance and risk management documents.

Sources

  1. ICH: The Common Technical Document (M4)
  2. European Commission: EudraLex Volume 2, Notice to Applicants (Volume 2B, presentation and content of the dossier)
  3. EUR-Lex: Directive 2001/83/EC on the Community code relating to medicinal products for human use (Annex I)

Put your CTD question to Workbench

Workbench answers regulatory questions from EUR-Lex, EMA, national agencies and your own documents, with every claim linked to its source. Start free with welcome credits.